Senior insider sale
General Counsel at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$347.0K
692.00 shares
What this filing means
KELLEY SHANNON T plans to sell 692.00 shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $347.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/20/2026ACC: 0001628280-26-002739
Officer· General Counsel
Since Mar 2026
692.00
Shares to sell
$347.0K
Approx. market value
263.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
1/16/2026
263.00Total acquired263.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/16/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 263.00 | — |
| Total | 263.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
429.00
Market value
$215.1K
1/20/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
263.00
Market value
$131.9K
1/20/2026
Total
Units
692.00
Value
$347.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 429.00 | $215.1K | — | Completed |
| Planned — Approximate Date | ||||
1/20/2026 | 263.00 | $131.9K | Nasdaq Stock Market | Planned |
| Total | 692.00 | $347.0K | ||